Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.09 -0.06 (-1.32%)
As of: Oct 21, 2026 · 11:37 AM EDT

Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026)

Updated

Oramed Pharmaceuticals (ORMP) reported Dividends payables of $264,000 for Q2 2026, down 12.9% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026) Analysis & Trends

At the end of FY2025, Oramed Pharmaceuticals posted Dividends payables of $10.6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 2.13 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 2.45 Bn
10 Oramed Pharmaceuticals 168.68 Mn -166.06 Mn - 264,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 264,000.00
Mar 31, 2026 303,000.00
Dec 31, 2025 10.60 Mn
API Access

Oramed Pharmaceuticals Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=ORMP&period=max&api_key=YOUR_API_KEY